Articles producció científica> Medicina i Cirurgia

Switching antiretroviral regimes for the treatment of HIV: safety implications

  • Dades identificatives

    Identificador: PC:1853
    Autors:
    Francesc VidalLaia UtrilloTeresa PuigPere Domingo
    Resum:
    DOI: 10.1080/14740338.2016.1206076 URL: http://www.tandfonline.com/doi/full/10.1080/14740338.2016.1206076 Filiació URV: SI
  • Altres:

    Autor segons l'article: Francesc Vidal; Laia Utrillo; Teresa Puig; Pere Domingo
    Departament: Medicina i Cirurgia
    Autor/s de la URV: VIDAL MARSAL, FRANCISCO; Laia Utrillo; Teresa Puig; Pere Domingo
    Paraules clau: toxicity
    Resum: Introduction: There are multiple reasons to switch from a virologically successful antiretroviral regimen. Some of them are related to toxicity. Lately, combination antiretroviral treatment (cART) switches have often been related to drug-drug interactions which may also eventually entail safety issues as well. Areas covered: The purpose of this review is to analyze causes of switching between virologically successful cART regimes related to safety issues. The most relevant papers were selected and summarized. Expert opinion: Switching cART has been a popular strategy to address safety issues throughout the antiretroviral era. The myriad of switching studies have paralleled the study and release into clinical practice of new antiretroviral drugs with different and often improved safety profiles. Most of them have been successful in improving antiretroviral toxicity while keeping HIV replication under control. However, it should be taken into account that, whenever a new drug is given, there is a possibility of new drug-related toxicity. Notwithstanding that, an increase in cART switching is foreseen, given the fact that we have a wide antiretroviral drug armamentarium and that people living with HIV are ageing and thus more prone to developing age-related co-morbidities whose therapies may entail new interactions and eventually new toxicities.
    Grup de recerca: Grup de Recerca Biomèdica HJ23
    Àrees temàtiques: Ciències de la salut Ciencias de la salud Health sciences
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 1474-0338
    Identificador de l'autor: N/D; N/D; N/D; N/D
    Data d'alta del registre: 2016-10-10
    Pàgina final: 1360
    Volum de revista: 15
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.tandfonline.com/doi/full/10.1080/14740338.2016.1206076
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI de l'article: 10.1080/14740338.2016.1206076
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2016
    Pàgina inicial: 1349
    Tipus de publicació: Article Artículo Article
  • Paraules clau:

    Toxicitat
    VIH (Virus)
    toxicity
    Ciències de la salut
    Ciencias de la salud
    Health sciences
    1474-0338
  • Documents:

  • Cerca a google

    Search to google scholar